Safety and Pharmacokinetics of Single Intravenous Doses of Peginesatide in Healthy Volunteers
Status:
Completed
Trial end date:
2005-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety, pharmacokinetics (PK), and minimum
pharmacologically active dose of peginesatide in Healthy Volunteers.